Evidence map›Paper›PMID 39119720›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Syphilis testing in blood donors, France, 2007 to 2022.

Syria Laperche, Claire Sauvage, Sophie Le Cam, Florence Lot, Lucile Malard, Pierre Gallian, Elodie Pouchol, Pascale Richard, Pascal Morel, Philippe Grange and 3 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Incidence ofEpidemiology and infection · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Syria LapercheDirection médicale, EFS Siège, Saint Denis, France.
Claire SauvageDirection des maladies infectieuses, Santé publique France, Saint Maurice, France.
Sophie Le CamDirection nationale, EFS Siège Saint Denis, France.
Florence LotDirection des maladies infectieuses, Santé publique France, Saint Maurice, France.
Lucile MalardDirection médicale, EFS Siège, Saint Denis, France.
Pierre GallianDirection médicale, EFS Siège, Saint Denis, France.
Elodie PoucholDirection médicale, EFS Siège, Saint Denis, France.
Pascale RichardDirection médicale, EFS Siège, Saint Denis, France.
Pascal MorelDirection nationale, EFS Siège Saint Denis, France.
Philippe GrangeCentre National de Référence des Infections Sexuellement transmissibles, Cochin Hospital, APHP, Paris, France.
Pierre TiberghienDirection nationale, EFS Siège Saint Denis, France.
Nadjet BenhaddouCentre National de Référence des Infections Sexuellement transmissibles, Cochin Hospital, APHP, Paris, France.
Nicolas DupinCentre National de Référence des Infections Sexuellement transmissibles, Cochin Hospital, APHP, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundSyphilis in blood donors (BD) has increased in many countries.AimWe aimed to describe trends in syphilis seroposivity in BD in France, to identify risk factors and assess if a non-treponemic test (NTT) could define BD having recovered from syphilis for more than 1 year.MethodsThe analysis covered the period 2007 to 2022 and 45,875,939 donations. Of the 474 BD syphilis-positive in 2022, 429 underwent additional investigations with an NTT. History of syphilis was obtained at the post-donation interview or based on serology results for repeat donors.ResultsUntil 2021, positivity rates remained stable (mean: 1.18/10,000 donations, range: 1.01-1.38). An increased rate was observed in 2022 (1.74/10,000; p = 0.02). Over the whole study period, prevalence was 2.2 times higher in male than in female BD (4.1 times higher in 2022). The proportion of males with an identified risk factor who have sex with men increased from 16.7% in 2007 to 64.9% in 2022. Based on NTT, 79 (18%) of the donors who were seropositive in 2022 were classified as having been infected in the previous year. History of syphilis was available for 30 of them. All had an infection within the previous 3 years. Among seven donors with a syphilis < 12 months before testing, one had an NTT titre ≥ 8, three a titre between 1 and 4, three were negative.ConclusionSyphilis seropositivity increased considerably in BDs in 2022, mostly in males, notably MSM. Available data did not allow appropriate evaluation of the NTT to distinguish recent from past infection.

Indexed as

Blood DonorsSyphilisSyphilis SerodiagnosisAdultFemaleFranceHomosexuality, MaleHumansMaleMiddle AgedPrevalenceRisk FactorsSeroepidemiologic StudiesTreponema pallidumYoung Adultblood donorsdiagnosticepidemiologyFrancescreeningsexually transmitted infectionsSyphilis

Identifiers

PMID39119720
PMCPMC11312016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.